Binh Dinh Pharmaceutical and Medical Equipment JSC Asset Resilience Ratio

Latest as of March 2026: 16.71%

Binh Dinh Pharmaceutical and Medical Equipment JSC asset resilience ratio. Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has an Asset Resilience Ratio of 16.71% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Binh Dinh Pharmaceutical and Medical Equ (DBD) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₫449.20 Billion
≈ $17.07 Million USD Cash + Short-term Investments

Total Assets

₫2.69 Trillion
≈ $102.11 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio of Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)

Asset resilience ratio of Binh Dinh Pharmaceutical and Medical Equipment JSC from 2020 to 2025. This chart shows how Binh Dinh Pharmaceutical and Medical Equipment JSC's Asset Resilience Ratio has changed over time. Read Binh Dinh Pharmaceutical and Medical Equ (DBD) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Binh Dinh Pharmaceutical and Medical Equipment JSC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Binh Dinh Pharmaceutical and Medical Equ's balance sheet.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₫0.00 0%
Short-term Investments ₫449.20 Billion 16.71%
Total Liquid Assets ₫449.20 Billion 16.71%

Asset Resilience Insights

  • Good Liquidity Position: Binh Dinh Pharmaceutical and Medical Equipment JSC maintains a healthy 16.71% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Binh Dinh Pharmaceutical and Medical Equipment JSC Industry Peers by Asset Resilience Ratio

Compare Binh Dinh Pharmaceutical and Medical Equipment JSC's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Ajanta Pharma Limited
NSE:AJANTPHARM
Drug Manufacturers - Specialty & Generic 14.99%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 5.50%
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
Drug Manufacturers - Specialty & Generic 26.45%
Porton Fine Chemicals Ltd
SHE:300363
Drug Manufacturers - Specialty & Generic 6.85%
Jubilant Pharmova Limited
NSE:JUBLPHARMA
Drug Manufacturers - Specialty & Generic 1.26%

Binh Dinh Pharmaceutical and Medical Equipment JSC Asset Resilience Ratio by Year (2020–2025)

Binh Dinh Pharmaceutical and Medical Equipment JSC asset resilience ratio by year from 2020 to 2025. The table below shows the annual Asset Resilience Ratio data for Binh Dinh Pharmaceutical and Medical Equipment JSC.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 15.84% ₫409.20 Billion
≈ $15.55 Million
₫2.58 Trillion
≈ $98.18 Million
+10.34pp
2024-12-31 5.50% ₫124.42 Billion
≈ $4.73 Million
₫2.26 Trillion
≈ $86.03 Million
-5.63pp
2023-12-31 11.12% ₫221.19 Billion
≈ $8.40 Million
₫1.99 Trillion
≈ $75.57 Million
-0.56pp
2022-12-31 11.68% ₫221.39 Billion
≈ $8.41 Million
₫1.90 Trillion
≈ $72.03 Million
+2.75pp
2021-12-31 8.93% ₫139.20 Billion
≈ $5.29 Million
₫1.56 Trillion
≈ $59.25 Million
+2.43pp
2020-12-31 6.49% ₫93.34 Billion
≈ $3.55 Million
₫1.44 Trillion
≈ $54.61 Million
--
pp = percentage points

About Binh Dinh Pharmaceutical and Medical Equipment JSC

VN:DBD Vietnam Drug Manufacturers - Specialty & Generic
Market Cap
$162.45 Million
₫4.28 Trillion VND
Market Cap Rank
#17109 Global
#100 in Vietnam
Share Price
₫45250.00
Change (1 day)
-0.11%
52-Week Range
₫45150.00 - ₫54400.00
All Time High
₫62000.00
About

Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company manufactures and trades in pharmaceuticals and medical equipment in Vietnam. It offers antibiotics; anticancer drugs; hemodialysis solutions; hepatobiliary drugs; analgesic and antipyretic drugs; drugs for muscles, bones, and joints; antihistamine anti-allergy drugs; ear, eye, nose, and throat drops; cardiovascular drugs; nervous … Read more